Global Green Chemicals Public Company Limited Management Discussion and Analysis | 1 Management Discussion and Analysis For the operating results of 1Q2019 Global Green Chemicals Public Company

financial statements for the 6 months ended June 30, 2019 as follows: Overview of Operating Performance Company and its subsidiaries had revenue classified by product category consist revenue from the

financial statements for the year ended December 31, 2019 as follows: Overview of Operating Performance Company and its subsidiaries had revenue classified by product category consist revenue from the

the 3rd quarter financial statements as of November 30, 2020 which were reviewed by Deloitte Touche Tohmatsu Jaiyos Audit Company Limited. The operating performance is summarized are as follows

December 2019 To : The President The Stock Exchange of Thailand Bangkok Chain Hospital Public Company Limited (the “Company”) would like to report the operating results for year ended 31 December 2019 which

the 3rd quarter financial statements as of November 30, 2021 which were reviewed by Deloitte Touche Tohmatsu Jaiyos Audit Company Limited. The operating performance is summarized are as follows

Unicorn Enterprises Limited (EBT of UE) • EBITDA and EBITDA margin were THB 131.6mn and 9.0% respectively, lower from the same period last year due to higher operating expense and a rise in selling and

to approve the cash dividend payment from the operating results of 2H 2017 of THB 0.018 per share (totaling THB 62mn). The total 2017 dividend payout was THB 122mn. The dividend was paid to

15 MAY 2018 2Q 2018 PERFORMANCE 2Q 2018 P&L SNAPSHOT AND ANALYSIS (THB mn) 2Q 2018 2Q 2017 YoY 1Q 2018 % QoQ Operating revenues 1,642.9 665.4 146.9% 1,335.4 23.0% Other revenues 148.1 82.5 79.5% 146.1

2020 To : The President The Stock Exchange of Thailand Bangkok Chain Hospital Public Company Limited (the “Company”) would like to report the operating results for the first quarter ended 31 March 2020